In addition to pathological α-synuclein, tau and Aβ staining used for typical neuropathological assessments, we also used an AD tau-selective antibody, GT-38 [21, 22], to investigate the type of tau present in LRRK2 PD. This evidence concerns the gene MAPT and Alzheimer disease.